PATENT CLAIM ANALYSIS

Application Number: 16052724
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["514", "549000"]

Abstract:
In various embodiments, the present invention provides methods of treating and/or preventing pediatric metabolic syndrome comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.

Claim (Index 1):
A method of treating a pediatric metabolic syndrome in a subject in need thereof, the method comprising:\n (a) identifying a subject as having pediatric metabolic syndrome; and (b) administering to the subject about 1 g to about 4 g of ethyl eicosapentaenoate per day.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 96.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13282145', '13711329', '13349157', '13349153', '13711324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.69433026456072
- 35 USC 102 Novelty (BERT): 0.522207370317349
- Combined Prediction Score: 0.6771179751363829
- Mean Citation Score: 291.38515399999994
- Max Citation Score: 292.50858
- Similarity Product: 190.827441780138

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test